ATE273022T1 - Verfahren zur verstärkung zellularer immunantworten - Google Patents

Verfahren zur verstärkung zellularer immunantworten

Info

Publication number
ATE273022T1
ATE273022T1 AT93921698T AT93921698T ATE273022T1 AT E273022 T1 ATE273022 T1 AT E273022T1 AT 93921698 T AT93921698 T AT 93921698T AT 93921698 T AT93921698 T AT 93921698T AT E273022 T1 ATE273022 T1 AT E273022T1
Authority
AT
Austria
Prior art keywords
immune responses
cellular immune
enhancing cellular
enhancing
immunogen
Prior art date
Application number
AT93921698T
Other languages
German (de)
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE273022T1 publication Critical patent/ATE273022T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93921698T 1992-09-28 1993-09-21 Verfahren zur verstärkung zellularer immunantworten ATE273022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28
PCT/US1993/008900 WO1994007531A1 (en) 1992-09-28 1993-09-21 Method of enhancing cell mediated immune responses

Publications (1)

Publication Number Publication Date
ATE273022T1 true ATE273022T1 (de) 2004-08-15

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921698T ATE273022T1 (de) 1992-09-28 1993-09-21 Verfahren zur verstärkung zellularer immunantworten

Country Status (11)

Country Link
EP (1) EP0839050B1 (enExample)
JP (1) JPH08502253A (enExample)
AT (1) ATE273022T1 (enExample)
AU (1) AU687750B2 (enExample)
CA (1) CA2145760A1 (enExample)
DE (1) DE69333588T2 (enExample)
DK (1) DK0839050T3 (enExample)
ES (1) ES2225825T3 (enExample)
MX (1) MX9306016A (enExample)
PT (1) PT839050E (enExample)
WO (1) WO1994007531A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001008636A2 (en) 1999-08-03 2001-02-08 The Ohio State University Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
BR0210804A (pt) * 2001-07-02 2005-05-03 Pfizer Prod Inc Vacinação de dose única com mycoplásma hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US7691396B2 (en) 2005-06-15 2010-04-06 The Ohio State University Research Foundation Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
JP5865350B2 (ja) 2010-05-11 2016-02-17 インターベット インターナショナル ベー. フェー. 母系由来の抗体の存在下での投与に適したマイコプラズマ・ハイオニュ−モニエに対するワクチン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
DE69128361T3 (de) * 1990-05-29 2006-04-13 Wyeth Holdings Corp. Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
EP0839050A1 (en) 1998-05-06
EP0839050A4 (enExample) 1998-05-06
JPH08502253A (ja) 1996-03-12
ES2225825T3 (es) 2005-03-16
EP0839050B1 (en) 2004-08-11
DK0839050T3 (da) 2004-10-25
AU687750B2 (en) 1998-03-05
DE69333588D1 (de) 2004-09-16
AU4931293A (en) 1994-04-26
PT839050E (pt) 2004-11-30
WO1994007531A1 (en) 1994-04-14
DE69333588T2 (de) 2005-08-04
MX9306016A (es) 1995-01-31
CA2145760A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
ES2059369T3 (es) Formulacion de vacuna.
IL96893A0 (en) Vaccines against cancer and infectious diseases
ATE127345T1 (de) Stressproteine und verwendungen dafür.
EE200100203A (et) Meetod immuunvastuse indutseerimiseks polüpeptiidse antigeeni vastu ja rakuga seotud polüpeptiidse antigeeni mahasurumiseks loomorganismil, selle meetodi kasutamine eesnäärme- ja rinnavähi raviks ning immunogeenne kompositsioon
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
FI943171A0 (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
ATE203677T1 (de) Legionellosis-impfstoffe und verfahren zur deren herstellung
DE69536091D1 (de) Immunisierung durch Impfung von DNS Transkriptionseinheit
DE3486292D1 (de) Tierärztliche Impfstoffe.
ES2031819T3 (es) Un metodo de preparar una proteina antigenica derivada de eimeriatenella.
ATE273022T1 (de) Verfahren zur verstärkung zellularer immunantworten
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
DE69132417D1 (de) Impfstoff gegen die Lyme-Krankheit
DK16087A (da) Mastitis-vaccine
DE68917138D1 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0636030A4 (en) VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA).
EP0339040A4 (en) Swine dysentery vaccine.
Toma et al. Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination
ZA806606B (en) Specific antigen vaccine for tge in swine
DK49685A (da) Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine
YU24401A (sh) Novi postupci za terapeutsku vakcinaciju
RU93008069A (ru) Способ иммунизации крупного рогатого скота

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0839050

Country of ref document: EP